Queensland will become a global mRNA vaccine hub with global healthcare company Sanofi partnering with Griffith University and other leading research institutions to establish a world-first research centre in south east Queensland.

Griffith University researchers will lead 17 new Discovery Projects across a broad field of knowledge after being awarded over $7.735 million from the Australian Research Council.

Griffith University, the Institute for Glycomics and Rotary are thrilled to announce The Honourable Anna Bligh AC will become the inaugural National Ambassador for its Malaria Vaccine Project.

A team of international scientists from Griffith University and the University of Alberta are about to start human clinical trials for a Strep A vaccine they hope will induce long-lasting immunity against the deadly pathogen which kills more than 500,000 people each year.

Griffith named in nation-wide research rankings.

Millions of lives are set to be changed for the better thanks to a landmark deal between Griffith University and Swiss-based company LimmaTech Biologics AG to develop a world-first gonorrhoea vaccine.

We are delighted to share some successful outcomes for NHMRC Investigator Fellowships announced on 12 October 2022 by the National Health and Medical Research Council (NHMRC).

Griffith University’s Institute for Glycomics is partnering with Sanctuary Cove Golf and Country Club for a third year to raise funds to aid vital breast cancer research.

A drug normally used to prevent tissue rejection following organ transplants could be repurposed to help treat human metapneumovirus (HMPV) infection in children.

Griffith University researchers have played a key role in investigating a new molecule that protects bacteria against viruses and is associated with bacterial infection of plants.

The ability to identify unique sugars that decorate ovarian cancer cells could help prevent the spread of cancer and improve treatment options for women.

Griffith University has launched two cancer research centres backed by $4.6 million in funding from the Australian Cancer Research Foundation this month.

New research has successfully switched off a key pathway of nerve fibre breakdown in debilitating neurodegenerative disorders

The Institute for Glycomics’ malaria vaccine researchers are one step closer to human trials for a malaria vaccine that can be freeze-dried.

Institute for Glycomics researchers awarded $1.1 million from NHMRC to develop new antibiotics for drug resistant gonorrhoea.

Researchers have received grants worth over $6.96 million from the Australian Research Council.

A Griffith study has found childhood COVID vaccination leads to high reductions in child disease and mortality, but is more beneficial to adults, particularly the unvaccinated.

Institute for Glycomics researchers receive funding boost in their fight against cancer with $2.6 million awarded by the Australian Cancer Research Foundation.